PDS Biotechnology Corp (PDSB)
3.49
-0.04
(-1.13%)
USD |
NASDAQ |
May 17, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Cash from Operations (Quarterly): -9.938M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.938M |
| December 31, 2023 | -8.457M |
| September 30, 2023 | -7.176M |
| June 30, 2023 | -4.814M |
| March 31, 2023 | -13.19M |
| December 31, 2022 | -7.529M |
| September 30, 2022 | -5.893M |
| June 30, 2022 | -5.919M |
| March 31, 2022 | -6.369M |
| December 31, 2021 | -4.501M |
| September 30, 2021 | -5.129M |
| June 30, 2021 | 0.9462M |
| March 31, 2021 | -3.802M |
| December 31, 2020 | -4.629M |
| September 30, 2020 | -1.252M |
| June 30, 2020 | -4.103M |
| March 31, 2020 | -3.164M |
| December 31, 2019 | -5.520M |
| September 30, 2019 | -4.328M |
| Date | Value |
|---|---|
| June 30, 2019 | -4.859M |
| March 31, 2019 | -3.367M |
| December 31, 2018 | -31.90M |
| September 30, 2018 | -0.4322M |
| June 30, 2018 | -0.4154M |
| March 31, 2018 | -0.4043M |
| December 31, 2017 | -9.240M |
| September 30, 2017 | -11.40M |
| June 30, 2017 | -9.284M |
| March 31, 2017 | -10.77M |
| December 31, 2016 | -6.046M |
| September 30, 2016 | -8.793M |
| June 30, 2016 | -8.275M |
| March 31, 2016 | -9.074M |
| December 31, 2015 | -6.783M |
| September 30, 2015 | -4.999M |
| June 30, 2015 | -5.706M |
| March 31, 2015 | -4.265M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.19M
Minimum
Mar 2023
0.9462M
Maximum
Jun 2021
-5.481M
Average
-4.994M
Median
Cash from Operations (Quarterly) Benchmarks
| Syros Pharmaceuticals Inc | -31.10M |
| PAVmed Inc | -13.11M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Chromocell Therapeutics Corp | -0.2572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 20.01M |
| Free Cash Flow | -30.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2855 |
| Free Cash Flow Yield | -27.17% |